reference/20360845

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20360845

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2314.e4
issn	2213-2198
issueIdentifier	6
pageRange	2305-2314.e4
publicationName	The Journal of Allergy and Clinical Immunology: In Practice
startingPage	2305
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_81157022b5fdeefce124d8c945a814a4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_47b82c0b9fd0c53483463fb1eb08a678 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_07de50c8423ed5a88b4b669a0a44bf62 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_847bbdff7a7ab73d9cf2ca37443a2b1b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cbc4b3259aba6838a5916c04db950a1d
bibliographicCitation	Wedner HJ, Aygören-Pürsün E, Bernstein J, Craig T, Gower R, Jacobs JS, Johnston DT, Lumry WR, Zuraw BL, Best JM, Iocca HA, Murray SC, Desai B, Nagy E, Sheridan WP, Kiani-Alikhan S. Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). The Journal of Allergy and Clinical Immunology: In Practice. 2021 Jun;9(6):2305–2314.e4. doi: 10.1016/j.jaip.2021.03.057.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d60b49186bf57437221263a94b30ca4c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d1ee7db9af25ddfd6f20d46e013cecd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16c6f9d8ca229c4e0d55c46b891a4587 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1140802977ba1d46303b4e9be84dbe6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72cd49555fa747a6d55b16f44c6d1072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d12ab086542194d03fa4f73547677044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_501f7642d3f46bb31b313abac8a54313 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_296157bba8fcce1b4ecdf1abc644360f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_012762447a0747e9599303cb88ad5932 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3aed5784fb4f74be7f4ec2e739ba4044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87c0691e012c813b5b5e3495dba354b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_474cfecae7f151250dcf1468229708ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d24b3134c269a1e7e4340659e854e51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab02b1e5ae75311c8f30660beb04ecdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad612fcd3fb27a1e80d86308162f31fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa444138a17d4f3694af148da1fde770
date	202106
identifier	https://pubmed.ncbi.nlm.nih.gov/33866032 https://doi.org/10.1016/j.jaip.2021.03.057
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40850 https://portal.issn.org/resource/ISSN/2213-2198
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)
discusses	http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M000733815
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054179Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D011720 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9772 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137528262 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11042 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9083

Total number of triples: 53.